RSSFDA fails checkup on drug effectiveness
From: The Washington Times | October 26, 2009
ASSOCIATED PRESS The Food and Drug Administration has allowed drugs for cancer and other diseases to stay on the market even when follow-up studies showed they didn’t save lives, congressional investigators say. And the agency has never pulled a drug off the market due to a lack of required follow-up about its actual benefits — even when such information is more than a decade overdue, according to a report due out Monday from the Government Accountability Office. When pressed about that policy, agency officials said they have no plans to get more aggressive. The GAO found that the FDA does …
Filed Under The Wire
Content posted by users from other sites is posted for commentary and news purposes under fair use and each author is responsible for their own postings and a particular posting should not be construed as being endorsed by this site or its owner.
Please Note: The comments section is for both the registered users of this web site as well as non-registered users. All wishing to post comments must comply with our Commenting Rules or risk having their comments stricken. Comments do not necessarily reflect the views of the ownership of this site and should not be taken as such just because they are visible and posted here.
Leave a Reply
Loading ...Recommended Reading:
